Billionaire Profile
Jorge Gallardo Ballart
Global Rank
#2934

Image: Unsplash Contributor | Unsplash License | via Unsplash

Jorge Gallardo Ballart

CEO, Pharmaceuticals
SPAIN
Real-Time Net Worth
$1.3B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.95% (24h)
Age
84
Source
pharmaceuticals
Industry
Healthcare
Citizenship
SPAIN

Biography

Jorge Gallardo Ballart, a Spanish billionaire, is a prominent figure in the pharmaceutical industry. With an estimated net worth of $1.3 billion as of 2024, he is primarily known for his long-standing association with Almirall, a major pharmaceutical company specializing in medical dermatology. Gallardo's wealth stems from his family's ownership and leadership within Almirall, which was founded in 1944. He holds a degree in Industrial Engineering and an MBA, and served as CEO of Almirall until 2011, later becoming Chairman. His career highlights include leading Almirall's successful IPO and spearheading the company's focus on medical dermatology, driving innovation and international expansion. Gallardo's legacy is built upon his strategic vision and commitment to R&D.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Jorge Gallardo Ballart was born on September 26, 1941, in Barcelona, Spain. He holds a degree in Industrial Engineering and an MBA from IESE Business School. Gallardo's career began within his family's pharmaceutical business, Almirall, founded in 1944 by his father, Antonio Gallardo Carrera.

Rise to Success

Gallardo joined Almirall in 1965 and was appointed CEO in 1972. Under his leadership, Almirall transformed from a local producer into a global specialty pharma firm. A pivotal moment was the company's successful IPO on the Madrid Stock Exchange in 2007, which secured the family's fortune. Gallardo served as CEO until 2011 and then became Chairman of the Board. His strategic focus on medical dermatology, acquiring key assets, and developing high-value treatments propelled the company's growth.

Key Business Strategies

Gallardo's success is attributed to his commitment to R&D, international expansion, and the specialization of the Spanish pharmaceutical industry. Almirall's focus on medical dermatology, including the acquisition of key assets and the development of treatments for conditions like psoriasis and actinic keratosis, was central to its growth strategy. He has been a key driver in the company's global success, with strong emphasis on innovation and patient-centric care. He also served as the President of EFPIA (European Federation of Pharmaceutical Industries and Associations) from 1998 to 2001.

Philanthropy

Jorge Gallardo Ballart is involved in philanthropy, supporting medical research and community initiatives through the Gallardo Health Foundation.

Career Milestones

1965

Joined Almirall

Began working at Almirall after completing his studies in Industrial Engineering.

1972

Completed MBA

Obtained an MBA from IESE Business School.

1987

CEO of Almirall

Became CEO of Almirall, leading the company's transformation.

2007

Almirall IPO

Oversaw the successful IPO of Almirall on the Madrid Stock Exchange.

2011

Chairman of the Board

Stepped down as CEO, becoming Chairman of the Board.

Philanthropy & Social Impact

Medical Research and Community Initiatives

Gallardo Health Foundation

Undisclosed

Supports medical research and community initiatives.